CNS pipeline · person
Julie Kim, MBA
Takeda's President and CEO, appointed by the Board in June 2026. She joined Takeda in 2019 through the acquisition of Shire and previously led the Plasma-Derived Therapies Business Unit and the U.S. Business Unit.
- 1 company
Courtesy Takeda
Current roles
- Takeda Pharmaceutical Company LimitedRepresentative Director, President and CEO · Executive
- Takeda Pharmaceutical Company LimitedRepresentative Director, President and Chief Executive Officer (Internal Director) · Board
Appears with
People sharing a company with Julie.
- Andrew S. Plump · Takeda Pharmaceutical Company Limited
- Awny Farajallah · Takeda Pharmaceutical Company Limited
- Masami Iijima · Takeda Pharmaceutical Company Limited
- Sarah Sheikh · Takeda Pharmaceutical Company Limited
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.